News Releases

Date	Title	Document
Date Apr 06, 2021	Title Oncocyte to Participate in Fireside Chat at the 20th Annual Needham Virtual Healthcare Conference	Document PDF
Date Mar 16, 2021	Title Oncocyte Provides Corporate Update and Reports Fourth Quarter and Annual 2020 Financial Results	Document PDF
Date Mar 16, 2021	Title Oncocyte Announces Peer-Reviewed Publication of Data Assessing Use of DetermaIO™ to Identify Patients Likely to Benefit from Immunotherapy Across Multiple Tumor Types	Document PDF
Date Mar 15, 2021	Title Oncocyte To Present New Data at 2021 American Association for Cancer Research (AACR) Annual Meeting Demonstrating Potential for Pan-Cancer Utility of DetermaIO™	Document PDF
Date Mar 09, 2021	Title Oncocyte Announces Formation of Medical Advisory Board	Document PDF
Date Mar 04, 2021	Title Oncocyte Announces Agreement with MultiPlan Network, Expanding Patient Access to DetermaRx™	Document PDF
Date Mar 03, 2021	Title Oncocyte to Report Fourth Quarter and Full Year 2020 Financial Results on Tuesday, March 16	Document PDF
Date Feb 25, 2021	Title Oncocyte Closes Second Investment In Razor Genomics to Complete Acquisition	Document PDF
Date Feb 23, 2021	Title Oncocyte to Begin Trading on the Nasdaq Stock Market on March 8, 2021	Document PDF
Date Feb 16, 2021	Title Oncocyte to Participate in Fireside Chat at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference	Document PDF